Abstract
Oligodendrocyte precursor cells (OPCs) have the ability to repair demyelinated lesions by maturing into myelin-producing oligodendrocytes. Recent evidence suggests that miR-219 helps regulate the differentiation of OPCs into oligodendrocytes. We performed oligodendrocyte differentiation studies using miR-219-overexpressing mouse embryonic stem cells (miR219-mESCs). The self-renewal and multiple differentiation properties of miR219-mESCs were analyzed by the expression of the stage-specific cell markers Nanog, Oct4, nestin, musashi1, GFAP, Tuj1 and O4. MiR-219 accelerated the differentiation of mESC-derived neural precursor cells (NPCs) into OPCs. We further transplanted OPCs derived from miR219-mESCs (miR219-OPCs) into cuprizone-induced chronically demyelinated mice to observe remyelination, which resulted in well-contained oligodendrocyte grafts that migrated along the corpus callosum and matured to express myelin basic protein (MBP). Ultrastructural studies further confirmed the presence of new myelin sheaths. Improved cognitive function in these mice was confirmed by behavioral tests. Importantly, the transplanted miR219-OPCs induced the proliferation of endogenous NPCs. In conclusion, these data demonstrate that miR-219 rapidly transforms mESCs into oligodendrocyte lineage cells and that the transplantation of miR219-OPCs not only promotes remyelination and improves cognitive function but also enhances the proliferation of host endogenous NPCs following chronic demyelination. These results support the potential of a therapeutic role for miR-219 in demyelinating diseases.
Similar content being viewed by others
Introduction
Progressive myelin loss within the central nervous system (CNS), known as demyelination, occurs as a consequence of oligodendrocyte death in diseases such as multiple sclerosis (MS)1. Although considerable remyelination is achieved by endogenous progenitor cells, the extent and quality of remyelination is limited. These limitations may arise because oligodendrocyte precursor cells (OPCs) fail to repopulate areas of demyelination or because they are unable to generate remyelinating oligodendrocytes due to the presence of inhibitory factors and/or a lack of the stimuli required to activate these cells to generate remyelinating oligodendrocytes2,3. Recently, studies involving the transplantation of different cell types (such as neural stem cells, Schwann cells, olfactory ensheathing cells, mesenchymal stem cells, and OPCs) into animal models of demyelination have shown promising results in enhancing myelin repair through multiple mechanisms, including cell replacement, trophic support, immunomodulation, and remyelination4,5,6,7,8. These studies have suggested that remyelination is a key mechanism in promoting functional recovery following demyelination.
OPCs are found in the adult human brain, constitute 5–8% of total glial cells, and are effective in experimental models of both congenitally dysmyelinated and adult demyelinated brains after transplantation9,10. The transplantation of ESC-derived OPCs has been shown to promote myelination and neurological function in some CNS disease or injury models such as those of spinal cord injury11,12, but some cases demonstrate no significant improvement because of limited cell survival, differentiation and migratory ability in an adverse mciroenviroment13. Thus, ESCs may serve as an unlimited experimental and therapeutic source of transplantable cells. Although different protocols for the differentiation of OPCs from ESCs have been reported, the efficiency of OPCs derived from ESCs is not very high (approximately 80–90%) for transplantation purposes, and in vitro culture of these cells is slow and tedious14,15,16. Several studies have shown that CNS remyelination is closely linked to the acute inflammatory phase of disease, whereas in the chronic stage, remyelination strategies fail, regardless of whether they involve inducing endogenous repair or cell transplantation-based therapy2,17,18. Thus, novel therapeutic approaches are needed to promote tissue repair.
Recent studies have demonstrated that the posttranscriptional control of gene expression by microRNAs (miRNAs) plays a critical role in oligodendrocyte development. Several microRNAs are induced concurrent with oligodendrocyte differentiation, including miR-219, miR-338, miR-138, miR-29, and miR-2319,20,21,22,23. Among the most abundant miRNAs in mature oligodendrocytes, miR-219 is necessary to promote oligodendrocyte differentiation, in part by directly targeting negative regulators of oligodendrocyte development such as PDGFRα, Sox6 and Hes5, all of which normally help promote OPC proliferation. Additionally, miR-219 downregulates NeuroD1 to suppress neuronal differentiation and shifts the transition of NSCs toward the oligodendrocyte lineage19. A recent study reported that human endometrial-derived stromal cells (EnSCs) can be programmed into pre-oligodendrocyte cells via the overexpression of miR-21924. Young and environmentally enriched exosomes deliver functional miR-219, which promotes oligodendrocyte differentiation and enhances myelination in aging rats25.
The evidence indicates that miR-219 plays a critical role in enabling the rapid transition from proliferating OPCs or NSCs to myelinating oligodendrocytes. The present study aims to give new insights into the role of miR-219 in the differentiation of mESCs into oligodendrocyte lineage cells in vitro and in an in vivo model of chronic experimental demyelination. We performed oligodendrocyte lineage cell differentiation studies using miR-219-overexpressing mESCs. To determine whether miR-219-overexpressing OPC grafts promote remyelination more efficiently in vivo, we transplanted OPCs derived from miR219-mESCs into cuprizone-induced chronically demyelinated mouse brains. The data demonstrate for the first time that miR-219 rapidly transforms mESCs into oligodendrocyte lineage cells in vitro and that miR219-OPCs transplantation not only promotes remyelination and improves cognitive function but also enhances host endogenous NPC proliferation following chronic demyelination. These data are a valuable resource with which to understand the potential therapeutic role of miR-219 in demyelinating diseases and to better manipulate ESCs for cell replacement therapy.
Results
miR219-mESCs maintained pluripotency
To observe the role of miR-219 in mESC differentiation, we followed the differentiation protocol shown in Fig. 1A. At 24 h, mESCs infected by miR-219 lentivirus were selected under 4 ng/ml puromycin. After the puromycin-resistant mESCs were passaged more than 10 times, both the miR-219 vector lentivirus-infected and the scramble vector lentivirus-infected mESCs presented as GFP-positive. RT-qPCR showed that miR-219 was successfully overexpressed in mESCs and that the relative miR-219 level in miR219-mESCs was 22.4 times higher than in the scramble group at 3 days (Fig. 1B, p = 0.0001). The selected cells were maintained in an undifferentiated proliferative state for 5 days; they were then switched to DIM medium for 8 days to form EBs. As expected, undifferentiated miR219-mESC colonies expressed strong GFP fluorescence and were positive for the mESC markers Nanog (Fig. 1C–E) and Oct4 (Fig. 1F–H). EBs were trypsinized and plated in N2 medium supplemented with bFGF for 7 days, as shown in Fig. 1I–N, and GFP-positive cells overlapped with the NPC markers nestin (Fig. 1I–K) and musashi1 (Fig. 1L–N). Upon exposure to terminal differentiation medium for 7 days, GFP/Tuj1 double-positive neurons (Fig. 1O–Q), GFP/GFAP double-positive astrocytes (Fig. 1R–T) and GFP/Galc double-positive oligodendrocytes (Fig. 1U–W), respectively, formed from the NPCs. The mRNA expression of Nanog, Oct4, nestin, musashi1, Tuj1, GFAP and Galc were consistent with the results of immunocytochemistry (Fig. 1X). Thus, we verified that miR-219 overexpression did not affect the properties of mESCs, which maintained pluripotency and were able to give rise to the three main CNS cell types upon differentiation.
MiR-219 accelerated the differentiation of mESCs along an oligodendrocyte linage
Although miR219-mESCs maintained pluripotency, it is not clear whether miR-219 influences the differentiation of mESCs into the oligodendrocyte lineage. To explore this question, we induced miR219-mESCs using the protocol shown in Fig. 2A to test the expression of NPC or OPC marker A2B5, the pre-oligodendrocyte marker NG2 and the immature oligodendrocyte marker O4. At 20 days, both scramble and miR-219 groups expressed strong A2B5 and NG2 fluorescence, no O4-positive cells were found in the scramble group, and a few O4-positive cells were detected in the miR-219 group (data not shown). Three days later (23 days), the expression of A2B5 (Fig. 2B–D) was still strong in the scramble group, and NG2 (Fig. 2E–G) and O4 (Fig. 2H–J) were detected with weak fluorescence. In the miR-219 group, the expression of A2B5 was decreased (Fig. 2K–M), whereas that of NG2 (Fig. 2N–P) and O4 (Fig. 2Q–S) was further increased with strong fluorescence. This overlapping expression of markers for early and late OPCs indicates cells at different developmental stages. The number of A2B5-positive cells was 4.78 times lower in the miR-219 group (Fig. 2X; 18.15 ± 3.82 versus scramble 86.05 ± 7.14), whereas the numbers of NG2- and O4-positive cells significantly increased in the miR-219 group compared to the scramble group (Fig. 2X; NG2 86.60 ± 6.93 versus scramble 41.42 ± 5.43; O4 42.51 ± 5.88 versus scramble 22.03 ± 3.57), suggesting that overexpression of miR-219 accelerated the differentiation of mESCs into OPCs.
Mature oligodendrocyte markers MBP and CNPase probed using immunocytochemistry showed that miR219-mESC derived OPCs (miR219-OPCs) were able to differentiate into mature oligodendrocytes in vitro, almost all oligodendrocytes that differentiated from miR219-OPCs were MBP positive (Fig. 2T–U) and CNPase positive (Fig. 2V–W).
MiR219-OPCs were associated with spinal axons in co-culture
The behavior of miR219-OPCs in vitro was observed by OPCs and spinal cord explants co-culture. Before co-culture, spinal cord explants were plated onto coverslips coated with 2% matrigel. Three days later, the neurites extended radially from the explants, but their somas remained in the explants; immunostaining showed that the neurites were positive for the neuron axonal marker NF-200 (Fig. 3A,B). Two weeks after co-culture, phase contrast micrographs showed that the oligodendrocytes that differentiated from miR219-OPCs exhibited multipolar morphology and attached to the neurites growing out from the spinal cord explants (Fig. 3C,D). Immunostaining confirmed that the processes of some GFP− positive oligodendrocytes had touched and elongated along the neurites (Fig. 3E,F), showing the association of the OPCs with spinal axons in co-culture.
Survival and differentiation of miR219-OPCs after transplantation
To assess whether miR-219 promotes a more effective transplant engraftment, OPCs derived from mESCs were injected by stereotaxic surgery into the corpus callosum of cuprizone-induced demyelinated mice. The injection site (Fig. 4A) was indicated by the presence of GFP-positive cells at 1 week after transplantation, and the survival and differentiation of OPCs were examined by fluorescent immunohistochemistry at 2, 4 and 8 weeks after transplantation.
We found that the majority of surviving GFP-positive cells remained NG2-positive with undifferentiated shapes in the scramble group at 2 weeks. In contrast, a minority of GFP-positive cells became negative for NG2 in the miR-219 group (Fig. 4B,E; 246.90 ± 25.30 versus scramble 53.63 ± 8.43/mm2), although the majority were MAG positive (data not shown). The data suggested that fewer NG2-positive OPCs had differentiated into immature or mature oligodendrocytes in the scramble group; however, miR-219 likely promoted the differentiation of OPC grafts in vivo.
At 4 weeks post-transplantation, a large fraction of GFP-positive cells in both groups co-expressed MAG, which is essential for the initiation of myelination. The number of MAG/GFP double positive cells in the miR-219 group was significantly increased compared to the scramble group (Fig. 4F; 373.83 ± 26.94 versus scramble 201.28 ± 20.73). Moreover, MAG/GFP double positive cells in the miR-219 group acquired a more mature oligodendrocyte shape (Fig. 4C), indicating that these cells had differentiated into oligodendrocytes, and miR-219 promoted the earlier maturation of oligodendrocytes, in accordance with observations from in vitro experiments.
Another structural protein, MBP, which plays a vital role in myelin compaction and thickening in the CNS, was observed for up to 8 weeks. MBP/GFP double positive cells seemed to wrap around neurites, and the bundles of MBP/GFP double positive nerve fibers were denser in the miR-219 group than in the scramble group (Fig. 4D). Mice in the miR-219 group had significantly increased MBP/GFP double positive IOD values compared with scramble group mice, as shown in Fig. 4G (3368.6 ± 321.2 versus scramble 1812.4 ± 219.1).
We also detected the activation of astrocytes and microglia (data not shown); a slight increase was detected for GFAP and Iba-1 expression in OPC transplanted mice compared with control mice, but an obvious decrease in GFAP and Iba-1 expression was observed in miR219-OPC transplanted mice compared with scramble mice. No tumor formation was observed in the mouse brains. Our results demonstrated that OPCs, which were generated in vitro from miR219-mESCs, can survive transplantation and effectively promote oligodendrocyte differentiation in vivo.
MiR-219 promoted remyelination in vivo
The extent of demyelination and remyelination during cuprizone exposure and recovery was further analyzed by LFB staining. At 12 weeks of cuprizone exposure, all myelin sheaths had been cleared in the corpus callosum of exposed mice (Supplementary Fig. 1B), whereas in the control group, the myelin sheaths were complete (Supplementary Fig. 1A), which was a significant difference between the groups (Supplementary Fig. 1F, p < 0.0001). Cuprizone-induced demyelination was followed by a recovery phase on a normal diet and HBSS injection for 8 weeks (vehicle group); remyelination was observed but was strongly limited. The amount of re-expressed myelin, as judged by LFB staining, was approximately 25.27% (Supplementary Fig. 1C,F). Transplantation of OPCs promoted remyelination, as shown in Supplementary Fig. 1D–F. The myelin scores significantly increased both in the scramble group and the miR-219 group compared with the vehicle group (scramble versus vehicle p < 0.05; miR-219 versus vehicle p < 0.01). Moreover, the myelin score was higher in the miR-219 group than in the scramble group (p < 0.05).
Toluidine blue staining of semi-thin sections of corpus callosum showed a significant decrease in the number of myelinated axons in mice with 12 weeks of a cuprizone diet followed by 8 weeks of a normal diet compared with control mice (Fig. 5A,B,F; p = 0.0002). In mice engrafted with OPCs, significantly enhanced numbers of myelinated axons were detected compared with vehicle group mice (Fig. 5D,E,F; scramble vs. vehicle p = 0.0193, miR219 vs. vehicle p = 0.0009). Interestingly, the number of myelinated axons in the miR219-OPC transplanted mice was greater than in the scramble-OPC transplanted mice (Fig. 5F; p = 0.0331), suggesting that miR-219 might be beneficial for remyelination.
Next, ultrastructure analyses were performed to show myelinated axons in the corpus callosum. Regular myelin sheaths were observed in mice fed normal chow (Fig. 5G). The mice showed the complete demyelination of axons after 12 weeks of cuprizone feeding (data not shown). After a 12-week cuprizone diet followed by 8 weeks of a normal diet, although some axons were remyelinated, the majority remained severely demyelinated. A number of large swollen axons with broken myelin sheaths was found, and the myelin sheaths broke down and compact layers split apart irregularly (Fig. 5H). In contrast, improved myelination was found in the corpus callosum of OPC-transplanted mice. However, some myelin sheaths still presented altered myelin structures, including hypomyelination, splits and vacuolated formations, especially in the scramble group. Less disturbed myelin sheaths and more compact and thicker myelin sheaths were found in the miR-219 group (Fig. 5I–J). Due to myelin thickness, we observed a significant increase in the g-ratio of vehicle samples compared to the control samples (Fig. 5K, p = 0.0013), and a significant decrease in the g-ratio of miR219-OPC transplanted samples compared to vehicle samples (Fig. 5K, P = 0.0100) and scramble samples (p = 0.0219). A further decrease in the g-ratio in the miR219 group was observed compared to the scramble group (Fig. 5K, P = 0.0402). The differences in the average axon diameter were not significant among the groups (Fig. 5L). These ultrastructural examinations revealed that miR219-OPC transplantation promoted remyelination more efficiently than scramble-OPC transplantation.
Transplanted OPCs are involved in the induction of endogenous NPC proliferation
The SVZ contains four main cell types defined by their morphology, ultrastructure, and molecular markers: migrating neuroblasts (type A cells), astrocytes (type B cells), proliferative precursors (type C cells) and ependymal cells (type E cells). A subpopulation of B cells are the primary NPCs, which are converted to transient amplifying type C cells that generate neuroblasts and glial cells26,27.
NPC transplantation has been reported to enhance host-derived myelin regeneration following chronic demyelination4. We examined the effect of OPC transplantation on the proliferation of SVZa cells in vivo. Semi-thin sections of SVZa showed no significant differences in total cell number among the control, vehicle and scramble groups (Fig. 6A,B,C,K). However, the total cell number in the SVZa was significantly increased in mice engrafted with miR219-OPCs compared with the vehicle group (Fig. 6D,K; p = 0.0136). We further analyzed the numbers of various cell types. The groups did not significantly differ in the numbers of type A or E cells. However, the total numbers of proliferating type B and type C cells in the SVZa were significantly increased in mice engrafted with miR219-OPCs compared with the vehicle group (Fig. 6L; p = 0.0151). The morphology of the four main cell types was further identified by ultrastructural examinations (Supplementary Fig. 2). The numbers of BrdU- and nestin-positive cells were detected in the SVZa by immunofluorescence (Fig. 6E–J). Cuprizone induced a significant decrease in BrdU- and nestin-positive cells compared with control mice (BrdU p = 0.0224; nestin p = 0.0003). However, miR219-OPCs grafts exhibited consistently elevated numbers of BrdU- and nestin-positive cells (Fig. 6M, BrdU p = 0.0075; nestin p = 0.0021). The numbers of BrdU-positive cells were significantly increased in the miR219 group compared to the scramble group (p = 0.0300).
OPC transplantation improves cognitive deficits in cuprizone-treated mice
Step-through passive avoidance task
In the acquisition trial, the initial latency did not differ among the four groups [non-significant versus ctrl group] (Fig. 7A). The step-through latency in the 24-h retention trial was significantly decreased in cuprizone-treated mice (vehicle vs. ctrl p = 0.0001). Analysis showed that OPC transplantation significantly inhibited the amnesic effect of the cuprizone diet on latency time for the step-through trial. The latency time was markedly increased in mice engrafted with scramble-OPCs or miR219-OPCs (scramble vs. vehicle group p = 0.021; miR-219 vs. vehicle p = 0.004). The latency time was further enhanced in the miR-219 group compared to the scramble group (p = 0.034).
Morris water maze task
Statistical analysis of the escape latency in the MWM task was performed using two-way ANOVA for repeated measures with day and treatment as the sources of variation (Fig. 7B). The results showed that mice fed the cuprizone diet had longer escape latencies than did control mice (which did not receive cuprizone) on Days 3 and 4 (p = 0.0260). A comparison between the vehicle group and the miR219 group showed that the transplantation of miR219-OPCs decreased the escape latency of mice fed the cuprizone diet (p = 0.0331), whereas the scramble group and the vehicle group had no significant differences in their spatial learning or memory abilities. All of the mice had the same levels of performance at the start of the experiment (no significant individual effects were observed for the first four trials of Day 1).
On the fifth testing day, the platform was removed, and the probe test was performed. The vehicle group spent less time swimming in the target quadrant (where the platform was located) than did the control group (p = 0.0063), whereas the scramble and miR-219 groups spent more time swimming in the target quadrant than did the vehicle group (scramble vs. vehicle p = 0.0310, miR-219 vs. vehicle p = 0.0205, Fig. 7C). The results also show a significant increase in the swimming time of miR-219 mice compared with scramble mice (p = 0.040, Fig. 7C).
Similar results were obtained for the mean number of times the animals crossed the place where the platform was located during training. The vehicle group mice crossed over the platform less frequently than the control mice did (p = 0.0047). The mean number of times significantly increased in the scramble and the miR-219 groups compared with the vehicle group (Fig. 7D, scramble vs. vehicle p = 0.0330, miR-219 vs. vehicle p = 0.018). A difference was also observed in the number of crossings of the scramble group and the miR-219 group (p = 0.044, Fig. 7D).
Discussion
Current studies using experimental animal models of demyelination are aimed at discovering therapeutic strategies to replace myelin under circumstances in which endogenous remyelination is unsuccessful. Here, we show for the first time that miR-219 rapidly transforms mESCs into oligodendrocyte lineage cells in vitro and that miR219-OPC transplantation not only promotes remyelination and improves cognitive function but also enhances host endogenous NPC proliferation in a chronic demyelination mouse model, thus suggesting a possible therapy for demyelinating diseases.
Protocols for the differentiation of ESCs to OPCs have been developed according to developmental principles28,29. However, the efficiencies of ESC differentiation into OPCs are inconsistent when the procedure is performed by different laboratories. It is necessary to purify ESC-derived OPCs and improve the survival and differentiation of myelinating oligodendrocytes to generate a safe population for use in regenerative therapy30. Genetic modifications have been made to ESCs to induce the expression of specific classes of transcription or growth factors to enhance OPC differentiation29,31,32. Furthermore, miRNAs can be tightly integrated into molecular pathways and cooperate to control the fate of ESCs. mESCs that lack miRNAs due to Dicer1 or Dgcr8 deficiency do not proliferate well and display severe differentiation defects33. Additionally, individual miRNA functions have been revealed in ESCs34,35. However, it is unknown whether miR-219 controls the oligodendrocyte lineage commitment of ESCs. Therefore, we explored the potential of miR-219 to promote ESC differentiation into an oligodendroglial lineage in vitro and the utility of miR219-OPCs as a cell replacement neuroprotective therapy.
We initially tested the effect of miR-219 on mESC differentiation without differentiating cocktails in vitro. Our results demonstrated that miR-219 overexpression did not affect the properties of mESCs, which maintained pluripotency and could be induced to form EBs and NPCs. Upon terminal differentiation, the three main types of neural cells (astrocytes, oligodendrocytes and neurons) in the CNS were obtained from NPCs, as previously described by others36. Gene expression analyses for markers of ESCs, NPCs and terminally differentiated cells further confirmed the results of immunocytochemistry. Moreover, the expression of A2B5, NG2 and O4 was not detected (data not shown) when these cells were maintained in mESC medium, which suggests that miR-219 might be a non-sufficient factor, not a switch, for mESC differentiation at an early stage.
Previous protocols have described the generation of an oligodendroglial lineage from mESCs at specific points in time14. Here, the capacity of miR219-mESCs to induce the differentiation of an oligodendrocyte linage was investigated by A2B5 and NG2 (OPC markers) and O4 (immature oligodendrocyte marker) immunocytostaining following the general protocol described above. For the first time, we found that the overexpression of miR-219 accelerated the differentiation of mESCs into OPCs. In differential medium containing FBS and T3, miR219-OPCs developed into mature oligodendrocytes by expressing CNPase and MBP, which is critical in the initial steps leading up to myelination. However, whether these glial cells shift to further axonal association and ensheathment to form myelin remains to be determined.
The in vitro models developed to investigate the growth and myelination of axons in the CNS, such as dorsal root ganglion (DRG) neuron–oligodendrocyte co-culture37, CNS neuron-oligodendrocyte co-culture38, and spinal cord explant-oligodendrocyte co-culture39, have revealed the mechanisms that underlie the interaction between neurons and myelinating cells. In this study, we used a spinal cord explant-oligodendrocyte co-culture model to observe the association of miR219-OPCs with spinal axons because without the interference of non-GFP somas, the interaction between GFP-oligodendrocytes and neurites could be observed clearly and dynamically without immunostaining. Two weeks after co-culture, the oligodendrocytes that differentiated from miR219-OPCs exhibited multipolar morphology, and the processes of some GFP-positive oligodendrocytes touched and elongated along the neurites, thus suggesting the association of OPCs with spinal axons. Of course, it is not sufficient to show only GFP and draw conclusions regarding myelination capacity here. Further examination with Sudan black, Caspr, or TEM is necessary to draw any meaningful conclusions.
No animal model completely recapitulates the complex pathomechanisms of human MS; animal models can mimic only parts of MS pathology. Cuprizone is a copper chelating reagent that, when added as a supplement to normal rodent chow, directly or indirectly causes oligodendroglial cell death with subsequent demyelination. Spontaneous remyelination is rapid and robust after acute demyelination [5 weeks of 0.2% (w/w) cuprizone administration]40,41. However, after a long exposure to cuprizone (12 weeks), known as chronic demyelination, spontaneous myelin regeneration no longer occurs for at least up to 9 weeks42,43. Thus, the cuprizone model has gained attention and acceptance in recent years because it is particularly suitable for investigating remyelination without the possible interference of peripheral immune cells such as macrophages and lymphocytes44,45. Here, we took advantage of the fact that chronic cuprizone exposure in C57BL/6 mice results in a less than 30% rate of spontaneous remyelination to study the role of miR219-OPCs after transplantation.
The transplantation of OPCs promotes remyelination and ameliorates experimental models of demyelination in the acute phase aside from remyelination, via neuroprotection, the suppression of inflammation, the promotion of axonal regeneration, and/or homeostatic maintenance13,46,47,48. The administration of thyroid hormone has been found to promote myelin repair under conditions of severe and chronic demyelination42. However, it is unknown whether ESCs-derived OPCs can promote remyelination in chronically demyelinated lesions, in which the pro-remyelinating effects of inflammation are diminished49. To this end, upon the transplantation of OPCs into chronically demyelinated mice, scramble-OPCs remained NG2 positive, and by 4 weeks, a minority of these cells began to differentiate into MAG-positive oligodendrocytes. By 8 weeks, a few MBP/GFP double positive nerve fiber bundles were detected in the corpus callosum. ESC-derived OPC transplantation faces huge challenges in chronic demyelination diseases because of the lack of a microenvironment that promotes OPC survival and differentiation50. Excitingly, miR219-OPCs grafts effectively survived and promoted mature oligodendrocyte differentiation in vivo. Moreover, ultrastructure analyses confirmed these observations by showing that the number of myelinated axons increased and the g-ratio decreased after transplantation. There is accumulating evidence that OPC transplantation-mediated neuroprotection occurs through a variety of mechanisms, including reducing endogenous neuronal and oligodendrocyte cell loss, stimulating the proliferation of endogenous progenitors, remyelinating the brain and providing neurotrophic support independent of directed differentiation48,51,52. Recently, Chen et al. suggested that transplanted OPCs not only survived and formed a myelin sheath but also stimulated BDNF and Bcl-2 expression and the proliferation of NSCs while inhibiting hypoxic-ischemic-induced neuronal apoptosis52. miR219-OPCs promote remyelination via direct differentiation and the formation of new oligodendrocytes. Otherwise, miR219-OPCs may benefit the environment by secreting neurotrophic factors or inhibiting inflammation.
Although the presence of OPCs throughout the CNS has been observed in MS patients, it is still undetermined to what extent OPC/NPC death occurs in MS lesions53, with subsequent reduction of the endogenous pools of these cells. Another important and unresolved question is whether the size of this pool directly impacts the efficiency of the repair process54. The SVZ and the parenchyma, which includes the white matter itself, are the two major sources of OPCs in the adult brain. Upon chronic cuprizone administration (12–16 weeks), newly generated oligodendrocytes progressively undergo apoptosis, and the pool of OPCs becomes diminished55. Armstrong et al. also reported that the density of PDGFαR+ cells was significantly increased during acute demyelination but decreased to untreated levels during chronic cuprizone administration. The density of Ki-67+ cells also declined during the recovery phase after 12 weeks of cuprizone56. Our data show that the number of proliferating OPCs decreased in chronic demyelinated mice, which is consistent with previous reports. However, we also found an increase in the total numbers of various cell types in the SVZa following miR219-OPC transplantation. miR219-OPC transplantation induced an increase in the number of proliferating NPCs, as confirmed by morphological analysis, BrdU labeling and nestin immunostaining. In the scramble group, there was a slight increase in NPCs but no obvious differences compared with the control and vehicle groups. In chronically demyelinated white matter, bone marrow-derived mesenchymal stromal cell (BM-MSC) transplantation activated endogenous OPCs originating from the SVZ and dentate gyrus and induced remyelination surrounding the grafted regions57. Here, we presume that endogenous NPCs may be beneficial to remyelination, but it is necessary to confirm the effects and mechanisms of these NPCs on remyelination.
Previous studies have shown that cuprizone-exposed mice display impaired spatial working memory58,59, decreased motor function60, and diminished social interaction59,61. Recently, Lewis rats fed with cuprizone exhibited demyelination and behavioral changes that share some similarities with white matter abnormalities observed in humans62. The abnormal behaviors, demonstrable demyelination, and oligodendrocyte loss observed in cuprizone-treated mice suggested a correlation between white matter damage and certain behavioral abnormalities. In this study, we first provided in vivo proof that OPC transplantation reverses cognitive deficits in cuprizone-induced demyelinated mice, as shown by the step-through passive avoidance task and the MWM test. The miR-219 group showed greater improvement on step-through test performance than the scramble group, suggesting that miR-219 facilitated cognitive functional improvement by promoting oligodendrocyte differentiation and remyelination. In addition, white matter repairment and endogenous NPCs proliferation might improve brain microenvironment which contributed to neurobehavioral function recovery.
In conclusion, remyelination strategies fail following demyelination because of obstacles to oligodendrocyte differentiation and maturation. Our findings demonstrate for the first time that miR-219 rapidly transforms mESCs into oligodendrocyte lineage cells in vitro. Moreover, miR219-OPC transplantation not only promotes remyelination and improves cognitive function but also enhances host endogenous NPC proliferation following chronic demyelination. These results support the potential therapeutic role of miR-219 in demyelinating diseases such as MS62.
Methods
Maintenance of mESCs
R1/E mESCs was obtained from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, and maintained as described in our previous studies29,63. In brief, mESCs were grown at an optimal density in gelatin (Sigma) coated dishes without feeder cells in Dulbecco’s modified Eagle’s medium (DMEM; GIBCO) supplemented with 10% fetal bovine serum (FBS; HyClone), 2 mM glutamine (Sigma), 1 mM sodium pyruvate (Sigma), 1× nonessential amino acids (NEAA; Invitrogen), 55 μM β-mercaptoethanol (Amresco), and 1 × 103 units/mL recombinant leukemia inhibitory factor (LIF; Sigma) in an environment containing 5% CO2 at 37 °C. The medium was changed every second day.
Differentiation of mESCs
Based on a previously established protocol64, the neural differentiation of mESCs was initiated using the protocol shown in Fig. 1A. Briefly, to generate embryonic bodies (EBs), mESC colonies were trypsinized into single cells and suspended in differentiation medium (DIM) consisting of α-minimal essential medium (а-MEM; HyClone) supplemented with 20% knockout serum replacement (KSR; GIBCO), 1 mM sodium pyruvate (Sigma), 0.1 mM NEAA (Invitrogen), and 0.1 mM β-mercaptoethanol (Amresco). The suspended cells from mESCs were cultured for 4 days in DIM and then cultured for another 4 days in DIM medium supplemented with 1 μM purmorphamine (Pur; Sigma) and 200 nM retinoic acid (RA; Sigma) to form EBs.
To induce the formation of neural precursor cells (NPCs), EBs were disaggregated in TrypLE (Invitrogen) on day 9 and plated on 6-well plates coated with poly-L-ornithine (0.002%; Sigma)/fibronectin (10 μg/ml; Millipore) or poly-L-ornithine (0.002%)/laminin (50 μg/ml; Sigma), DMEM/F12 (GBICO) supplemented with 10 ng/ml basic fibroblast growth factor (bFGF; Invitrogen), 1 μM Pur (Sigma), 200 nM RA (Sigma) and 1% N2 medium (GBICO) was used at this stage for 7 days.
To promote the further differentiation of NPCs, on day 21, the medium was replaced with DMEM/F12 medium with 1% FBS but maintained without bFGF, RA, or Pur for 7 days.
To generate OPCs, on day 15, the NPCs were cultured in DMEM/F12 supplemented with 10 ng/mL bFGF, 10 ng/mL platelet-derived growth factor-AA (PDGF-AA; Invitrogen), 1% N2 and 2% KSR for up to 28 days. Then, PDGF-AA and bFGF were excluded from the OPC medium, and 3,3′5′-triido-L-thyronine (T3, 30 ng/ml; Sigma) and 10% FBS were added to differentiate the OPCs into oligodendrocytes.
Preparation of miR-219 lentivirus expression vector and transfection
The miR-219 locus on chromosome 2 and its approximately 200 bp flanking sequences were PCR amplified from mouse genomic DNA and inserted into the GV254 vector (the functional element is Ubi-EGFP-MCS-IRES-Puromycin) to form miR219-GV254 recombinant plasmids. To generate the scrambled miRNA construct, the control sequence “TTCTCCGAACGTGTCACGT” was inserted. Recombinant lentivirus was prepared by transient cotransfection of HEK 293 T cells with the appropriate transfer vector and lentiviral helper plasmids (20 μg pGC-LV, 15 μg pHelper 1.0, 10 μg pHelper 2.0) using Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer’s instructions. After 8 h of incubation, the medium was exchanged with fresh medium. On the following day, the lentivirus was harvested, filtered through a 0.45-μm filter and concentrated by ultracentrifugation (140 min at 50,000 × g). Viruses were titered by flow cytometry and then used to infect HEK 293 T cells. Titers for the preparations used here were 2 × to 5 × 108 infectious units/ml. mESCs were infected with LV-miR-219 at a multiplicity of infection (MOI) = 100 when mESCs grew until 80–90% confluent in serum-free Opti-MEM (GBICO).
RNA extraction and RT-qPCR
To use qRT-PCR to analyze miR-219 expression, RNA samples were obtained from mESCs cultured for 3 days. Taqman miRNA RT-qPCR analysis was performed on 10 ng of RNA for the indicated miRNAs, following the manufacturer’s protocol (Applied Biosystems) and normalized to U6 snRNA. SYBR Green incorporation RT-qPCR was used to detect mouse mRNA expression as performed on an ABI StepOnePlus Real Time PCR system following the manufacturer’s instructions, then normalized to GAPDH mRNA levels.
To use RT-PCR to analyze gene expression, RNA was purified from mESCs, NPCs and terminally differentiated cell samples using the Qiagen RNeasy Mini Kit, and 400 μg of total RNA was reverse-transcribed using a First Strand cDNA Synthesis kit (Takara). The data were analyzed using the ddCt method. All primers are provided in Table 1.
OPCs-spinal cord explant co-culture
The miR219-OPCs and spinal cord explant co-culture was conducted as described previously65. Glass coverslips treated with 25 mM HCl were coated in 2% Matrigel in 6-well plates. OPCs derived from miR219-mESCs were cultured for 8–10 days prior to co-culture following above protocols. Embryonic Sprague–Dawley (SD) rats at 14.5–16 days of gestation were removed from their pregnant mothers and transferred to a 100-mm Falcon culture dish that contained Hanks’ balanced salt solution (HBSS; Invitrogen). Their vertebral canals were opened and spinal cords were removed rapidly into another 100-mm dish that contained HBSS, using sterile fine-tipped forceps and micro-spring scissors. After the meninges and blood vessels were removed carefully, the embryonic spinal cords were cut into small pieces (no more than 0.5 mm in length) by scissors, which would be used as spinal cord explants. Spinal cord explants were plated onto miR219-OPCs and allowed to grow for 2 weeks before fixation and immunolabeling. The co-culture medium consists of DMEM/F12 and Neurobasal (1:1), 1% N2 medium, 2% B27, 2 mM glutamine (GBICO), 0.1% BSA, 10 ng/ml biotin and 30 ng/ml T3 (Sigma).
Immunocytochemistry
mESCs and differentiated cultures were fixed with 4% paraformaldehyde (Sigma) and permeabilized with 0.3% Triton™ X-100 (Sigma) followed by 1 h of blocking with 10% goat serum (Sigma) and were incubated overnight with primary antibodies at 4 °C. The following primary antibodies were used: for ESC, Nanog (rabbit IgG, 1:500, Abcam) and Oct4 (rabbit IgG, 1:200, CST); for NPC, nestin (mouse IgG1, 1:1000, Abcam) and musashi1 (rabbit IgG1, 1:100, Sigma); for neurons, β3-tubulin (Tuj1, rabbit IgG, 1:100, Santa Cruz Biotechnology, USA); for astrocytes, glial fibrillary acidic protein (GFAP; rabbit IgG, 1:300, Abcam); for oligodendrocytes, Galc (mouse IgG1, 1:500, Abcam), cyclic nucleotide 3′ phosphodiesterase (CNPase; mouse IgG1, 1:100, Santa Cruz Biotechnology, USA) and myelin basic protein (MBP; mouse IgG1, 1:500, Covance); for OPCs, A2B5 (rabbit IgG, 1:200, Abcam) and NG2 proteoglycan (rabbit IgG, 1:200, Millipore); for pre-oligodendrocytes, O4 (mouse IgG1, 1:200, Sigma); and for neuron axons, NF-200 (rabbit IgG1, 1:500, Abcam). For negative controls, cells were incubated with PBS instead of the primary antibodies. Subsequently, incubation with secondary antibodies was performed for 2 h at room temperature. The secondary antibodies used were: goat anti-mouse IgG (H + L) Alexa Fluor ®555 conjugated or goat anti-rabbit IgG (H + L) Alexa Fluor ®555 (1:500, Invitrogen, Eugene, OR, USA). Nuclei were stained with 4,′6-diamidino-2-phenylindole, DAPI (Sigma, USA). Fluorescence images were captured using a Zeiss Axioskop 40 microscope (Carl Zeiss, Oberkochen, Germany).
Animals and administration
Eight-week-old wild-type C57BL/6 male mice were purchased from Shanghai Laboratory Animal Center (Shanghai, China). Experimental chronic demyelination was induced by feeding mice a diet containing 0.2% (w/w) cuprizone [bis–cyclohexanone-oxaldihydrazone] (Sigma) mixed into a ground standard rodent chow for 12 weeks41. Untreated control mice were maintained on a diet of normal pellet chow.
For transplantation, the cuprizone-induced mice were anesthetized with 3% isoflurane in a mixture of air and 100% oxygen (1:1) and positioned in a stereotaxic apparatus. They then received a single injection of 2 μl scramble-OPCs (scramble group, n = 17) or miR219-OPCs [miR-219 group, n = 17, (1 × 105 cells/μl Hank’s Balanced Salt Solution, HBSS)] injected for 0.2 μl/min at the coordinates: anterior-posterior +0.5, medial-lateral ±1.2, and dorsal-ventral −2.5 (Paxinos and Franklin, 2001). The vehicle group received an injection of 2 μl HBSS.
For the immunosuppressive therapy protocol, OPC-transplanted mice received tacrolimus (TAC; Sigma- Aldrich) and sirolimus (SIR; Rapamune oral solution; Sigma-Aldrich). TAC and SIR were administered once daily by oral gavage, 4 mg/kg/d for TAC, and 3 mg/kg/d for SIR. To label proliferating cells, bromodeoxyuridine (BrdU, 50 mg/kg; Sigma, St. Louis, MO, USA) was injected intraperitoneally daily during the last 3 days before perfusion. All procedures in the experiment were consistent with Chinese legislation on the use and care of laboratory animals and were approved by the Xuzhou Medical University committee for animal experiments.
Behavioral tests
All of the behavioral experiments were performed during the seventh week after transplantation. Each group contained eight mice.
Step-through passive avoidance task
The step-through passive avoidance apparatus consisted of an illuminated chamber (11.5 cm × 9.5 cm × 11 cm) lit with a 25 W lamp, attached to a darkened chamber (23.5 cm × 9.5 cm × 11 cm) containing a metal floor that was capable of delivering a mild electric shock (0.3 mA, 50 Hz, 5 s). A guillotine door separated the two compartments. The step-through test was performed as previously described66,67. Briefly, mice were placed in a dimly lit room containing the apparatus for 0.5 h before training, to allow them to acclimatize to the new environment. Each mouse was placed into the illuminated chamber, facing away from the door into the dark chamber, and allowed to acclimatize for 1 min. As soon as the mouse entered the dark chamber, the door was slid back into place, triggering an electric shock. The mouse was immediately removed from the chamber and returned to its cage. The latency (time used to change compartments) was recorded. The retention test was conducted 24 h later with the mouse again being placed in the illuminated chamber and subjected to the same protocol but without the electric shock. The upper time limit was set at 300 s.
Morris Water Maze test
The Morris Water Maze (MWM) test was performed as previously described66,67.The experimental apparatus consisted of a circular water tank (100 cm in diameter, 35 cm in height), containing water (23 ± 1 °C) to a depth of 15.5 cm, which was rendered opaque by adding milk powder. A platform (4.5 cm in diameter, 14.5 cm in height) was submerged 1 cm below the water surface and placed at the midpoint of one quadrant. The pool was located in a test room that contained various prominent visual cues. Each mouse received four training periods per day for 4 consecutive days. The latency to escape from the water maze (by finding the submerged escape platform) was calculated for each trial. On day 5, the probe test was performed by removing the platform and allowing each mouse to swim freely for 60 s. The time that the mice spent swimming in the target quadrant (where the platform was located during hidden platform training) and in the three nontarget quadrants (right, left and opposite quadrants) was measured, respectively. For the probe trials, the number of times each mouse crossed over the platform site was also measured and calculated. All data were recorded with a computerized video system.
Tissue preparation
Mice from each group at 1 week (n = 3), 2 weeks (n = 3), 4 weeks (n = 3) and 8 weeks (n = 4) after transplantation were intracardially perfused with PBS followed by fixation with 4% cold paraformaldehyde. The brains were removed and post-fixed in 4% paraformaldehyde for 6 h at 4 °C, incubated overnight at 4 °C in 100 mM sodium phosphate buffer (pH 7.4) containing 30% sucrose, and then embedded in Optimal Cutting Temperature medium (Leica Microsystems, Nussloch, Germany) for cryosectioning. Coronal sections (10 μm or 20 μm) from the bregma anterior-posterior +1.0 to −1.0 were cut and collected on 3-aminopropyltriethoxysilane-coated slides (Sigma-Aldrich) and stored at −80 °C. Ten-micron composite sections were stained routinely with LFB-PAS, and 20 μm sections were stained by immunohistochemistry.
Histology and immunohistochemistry
The extent of myelination in the corpus callosum was examined by staining coronal brain sections with Luxol Fast Blue and Periodic Acid-Schiff (LFB-PSA, Sigma). The sections were scored based on the relative ratio of blue or pink fibers detected visibly by the observer, on a scale from zero to three, with three being completely myelinated and zero being completely demyelinated. Intermediate scores in 0.25 increments reflect partial demyelination68.
For immunohistochemistry, primary antibody NG2 proteoglycan (rabbit IgG, 1:200, Millipore), myelin associated glycoprotein (MAG, rabbit IgG, 1:100, Santa Cruz Biotechnology, USA), MBP (mouse IgG, 1:500, Covance), GFAP (rabbit IgG, 1:300, Abcam), Iba-1(rabbit IgG, 1:1000, Wako), BrdU (rabbit IgG, 1:1000; Abcam, Cambridge, UK) and nestin (mouse IgG,1:1000; BD PharMingen, Inc., San Diego, CA, USA) were used. For negative controls, sections were incubated with PBS instead of the primary antibodies. After PBS washes, sections were incubated for 1 h with secondary antibodies: goat anti-mouse IgG (H + L) Alexa Fluor ®555 conjugated or goat anti-rabbit IgG (H + L) Alexa Fluor ®555 (1:500, Invitrogen, Eugene, OR, USA). The specificity of the staining was assessed by omitting the primary antibody. Slides were mounted with Mowiol (Calbiochem, USA) containing DAPI (Sigma, USA) according to the manufacturer’s instructions. For BrdU staining, sections were pretreated with 50% formamide/280 mM NaCl/30 mM sodium citrate at 65 °C for 2 h, incubated in 2 M HCl at 37 °C for 30 min, and rinsed in 0.1 M boric acid (pH 8.5) at room temperature for 10 min.
The counting of NG2/GFP or MAG/GFP double-positive cells in the corpus callosum was performed in three sections per animal from the same levels, at every 9–12th section between bregma levels +1.0 and 0.02 mm. Areas of interest were scanned with a 20 × objective lens in 600 μm × 450 μm format in the x–y direction. The number of NG2/GFP or MAG/GFP double-positive cells in each field was then converted into the number of double-positive cells/mm2. To determine the number of BrdU- or nestin-labeled cells in the anterior subventricular zone (SVZa), we selected every 13–15th section between bregma levels +1.0 and 0.02 mm (total = 3 sections per brain). In each section, a rectangle of 200 μm × 100 μm per side was placed within the SVZa, and the total number of positive cells per rectangle was counted69.
For quantitative analysis of the MBP immunofluorescence staining, integral optical density (IOD) and a region of interest were measured by Image-Pro Plus 6.0 software (Media Cybernetics Inc., USA). Values (three slides for each brain) of optical density in individual cells represented the quantity of objective protein and were calculated using the following equation: ΣIOD/ΣArea, where IOD is the integral optical density in a region of interest, and area is the area of a region of interest. In this study, ΣIOD is the sum of the IOD of MBP/GFP double-positive cells in the photograph, and ΣArea is the total area of MBP-positive cells in the photograph64.
Electron microscopy
For electron microscopic examination, Epon embedding was performed as previously described70. In brief, four animals per group were transcardially perfused with 2% glutaraldehyde (Gla) and 2.5% PFA in 0.1 M PBS. Brains were quickly removed and placed on ice. The corpus callosum was dissected, and the samples were placed in a tube. Immediately after extraction, samples were placed in 3% Gla in 0.1 M cacodylate buffer (pH 7.4) at 4 °C overnight and transferred to 1% osmium tetroxide in the same buffer for 1 h at room temperature. Tissue was transversely cut into 1 mm blocks that were fixed in osmium tetroxide at 4 °C overnight, dehydrated through ascending ethanol washes, and embedded in epoxy resin. To study the remyelinated axons of the corpus callosum, serial 1 μm-thick semi-thin sections were cut with a diamond knife, stained with 1% toluidine blue, and examined by light microscopy. To analyze myelin sheaths in the corpus callosum, 60–70 nm-thick ultra-thin sections were stained with uranyl acetate and lead citrate prior to examination by tEM (FEI Tecnai G2 T12, USA), and the image was analyzed by TEM Imaging and Analysis, TIA.
For morphometric analysis, we measured at least 100 axons. We counted the total number of axons with and without myelin sheaths contained within all of the selected electron micrographs from each animal. We measured the axonal diameter (d) as the shortest distance across the center of the axon, avoiding the myelin sheath thickness. The axonal diameter plus the total myelin sheath thickness on both sides was defined as the fiber diameter (D). The g-ratio was calculated using the d/D ratio. Therefore, a completely demyelinated fiber would have a g-ratio = 1, and myelinated fibers would have a ratio of <1. The g-ratio was calculated for each myelinated fiber, then the average of all the g-ratio values from one brain was calculated. The mean of the average g-ratios from the three brain samples was determined for each group71,72.
Statistical analysis
All statistical analyses were performed with SPSS software, version 11.5. Group differences in the escape latency in the MWM training task were analyzed using two-way ANOVA. The other data were analyzed using Student’s t-test or one-way ANOVA. The data are expressed as the mean ± s.e.m. Statistical significance was set at P < 0.05 for all tests.
Additional Information
How to cite this article: Fan, H.-B. et al. Transplanted miR-219-overexpressing oligodendrocyte precursor cells promoted remyelination and improved functional recovery in a chronic demyelinated model. Sci. Rep. 7, 41407; doi: 10.1038/srep41407 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Dutta, R. & Trapp, B. D. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 93, 1–12 (2011).
Chang, A., Tourtellotte, W. W., Rudick, R. & Trapp, B. D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl.J. Med. 346, 165–173 (2002).
Foote, A. K. & Blakemore, W. F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128, 528–39 (2005).
Einstein, O., Friedman-Levi, Y., Grigoriadis, N. & Ben-Hur, T. Transplanted neural precursors enhance host brain-derived myelin regeneration. J. Neurosci. 29, 15694–15702 (2009).
Hawryluk, G. W. et al. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 21, 2222–2238 (2012).
Hawryluk, G. W. et al. An examination of the mechanisms by which neural precursors augment recovery following spinal cord injury: a key role for remyelination. Cell Transplant. 23, 365–380 (2014).
Nazm Bojnordi, M., Ghasemi, H. H. & Akbari, E. Remyelination after lysophosphatidyl choline-induced demyelination is stimulated by bone marrow stromal cell-derived oligoprogenitor cell transplantation. Cells Tissues Organs. 200, 300–306, doi: 10.1159/000437350 (2014).
Azimi Alamouti, M. et al. Remyelination of the corpus callosum by olfactory ensheathing cell in an experimental model of multiple sclerosis. Acta. Med. Iran. 53, 533–539 (2015).
Windrem, M. S. et al. Progenitor cells derived from the adult human subcortical white matter disperse a-nd differentiate as oligodendrocytes within demyelinated lesions of the ratbrain. J. Neurosci. Res. 69, 966–975, doi: 10.1002/jnr.10397 (2002).
Windrem, M. S. et al. Neonatal chimerizationwith human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2, 553–565, doi: org/10.1016/j.stem.2008.03.020 (2008).
Sharp, J., Frame, J., Siegenthaler, M., Nistor, G. & Keirstead, H. S. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem cells 28, 152–63, doi: 10.1002/ stem. 245 (2010).
Piao, J. et al. Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell 16, 198–210, doi: 10.1016/j.stem.2015.01.004. (2015).
Lü, H. Z., Wang, Y. X., Zhou, J. S., Wang, F. C. & Hu, J. G. Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation. BMC Neurosci. 11, 127, doi: 10.1186/1471-2202-11-127. (2010).
Billon, N., Jolicoeur, C., Ying, Q. L., Smith, A. & Raff, M. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J. Cell. Sci. 115, 3657–3665 (2002).
Jiang, P., Selvaraj, V. & Deng, W. Differentiation of embryonic stem cells into oligodendrocyte precursors. J. Vis. Exp. 39, e1960, doi: 10.3791/1960 (2010).
Jiang, P. et al. Generation and characterization of spiking and nonspiking oligodendroglial progenitor cells from embryonic stem cells. Stem Cells 31, 2620–2631, doi: 10.1002/ stem.1515 (2013).
Keirstead, H. S. et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants re-myelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694–4705 (2005).
Karimi-Abdolrezaee, S., Eftekharpour, E., Wang, J., Morshead, C. M. & Fehlings, M. G. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J. Neurosci. 26, 3377–3389 (2006).
Dugas, J. C. et al. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65, 597–611 (2010).
Zhao, X. et al. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65, 612–626, doi: 10.1016/j.neuron.2010.02.018 (2010).
Shin, D., Howng, S. Y., Ptáček, L. J. & Fu, Y. H. MiR-32 and its target SLC45A3 regulate the lipid metabo-lism of oligodendrocytes and myelin. Neuroscience 213, 29–37 (2012).
De Faria, O. Jr. et al. Regulation of miRNA 219 and miRNA clusters 338 and 17–92 in oligodendrocytes. Front. Genet. 3, 46 (2012).
Kuypers, N. J., Bankston, A. N., Howard, R. M., Beare, J. E. & Whittemore, S. R. Remyelinating oligodendrocyte precursor cell miRNAs from the sfmbt2 cluster promote cell cycle arrest and differentiation. J. Neurosci. 36, 1698–1710, doi: 10.1523/JNEUROSCI.1240-15.2016 (2016).
Ebrahimi-Barough, S. et al. Programming of human endometrial-derived stromal cells (EnSCs) into pre-oligodendrocyte cells by overexpression of miR-219. Neurosci. Lett. 14, 65–70 (2013).
Pusic, A. D. & Kraig, R. P. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination. Glia 62, 284–299, doi: 10.1002/glia.22606 (2014).
Doetsch, F., Caillé, I., Lim, D. A., García-Verdugo, J. M. & Alvarez-Buylla, A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97, 703–716 (1999).
Quiñones-Hinojosa, A. et al. Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J. Comp. Neurol. 494, 415–434, doi: 10.1002/cne.20798 (2006).
Tabar, V. & Studer, L. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat. Rev. Genet. 15, 82–92, doi: 10.1038/nrg3563 (2014).
Yao, R. et al. Olig2 overexpression accelerates the differentiation of mouse embryonic stem cells into oligodendrocyte progenitor cells in vitro . Dev. Growth. Differ. 56, 511–517, doi: 10.1111/dgd.12150 (2014).
Sadowski, D. et al. Teratogenic potential in cultures optimized for oligodendrocyte development from m-ouse embryonic stem cells. Stem. Cells. Dev. 19, 1343–1353, doi: 10.1089/scd.2009.0520 (2010).
Tamaki, S. & Tokumoto, Y. Overexpression of cyclin dependent kinase inhibitor P27/Kip1 increases oligodendrocyte differentiation from induced pluripotent stem cells in vitro . Cell. Dev. Biol. Anim. 50, 778–785 doi: 10.1007/s11626-014-9753-2 (2014).
Salehi, M., Ardeshirylajimi, A., Mossahebi-Mohammadi, M., Kondori, Z. & Jorjani, M. Oligodedrocyte progenitor cells differentiation of nuclear transferred mouse embryonic stem cells. Cell. Mol. Biol. 61, 56–59 (2015).
Murchison, E. P., Partridge, J. F., Tam, O. H., Cheloufi, S. & Hannon, G. J. Characterization of Dicer-deficient murine embryonic stem cells. Proc. Natl. Acad. Sci. USA 02, 12135–40 (2005).
Heinrich, E. M. & Dimmeler, S. MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. Circulation Research 110, 1014–22, doi: 10.1161/CIRCRESAHA.111.243394 (2012).
Kanellopoulou, C. et al. Reprogramming of polycomb-mediated gene silencing in embryonic stem cells by the miR-290 family and the methyltransferase ash1l. Stem Cell Reports. 5, 971–8, doi: 10.1016/j.stemcr.2015.10.001 (2015).
Reynolds, B. A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mam-malian central nervous system. Science 255, 1707–1710 (1992).
Wang, Z., Colognato, H. & Ffrench-Constant, C. Contrasting effects of mitogenic growth factors on myelination in neuron–oligodendrocyte co-cultures. Glia 55, 537–545, doi: 10.1002/glia.20480 (2007).
Thomson, C. E., Hunter, A. M., Griffiths, I. R., Edgar, J. M. & McCulloch, M. C. Murine spinal cord explants: a model for evaluating axonal growth and myelination in vitro . J. Neurosci. Res. 84, 1703–1715,doi: 10.1002/jnr.21084 (2006).
Chen, Z. et al. Oligodendrocyte-spinal cord explant co-culture: an in vitro model for the study of myelination. Brain Res. 1309, 9–18 (2010).
Kipp, M., Clarner, T., Dang, J., Copray, S. & Beyer, C. The cuprizone animal model: new insights intoan old story. Acta Neuropathol. 118, 723–736, doi: 10.1007/s00401-009-0591-3 (2009).
Skripuletz, T., Gudi, V., Hackstette, D. & Stangel, M. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol. Histopathol. 26, 1585–1597 (2011).
Harsan, L. A. et al. Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J. Neurosci. 28, 14189–14201 (2008).
Hussain, R. et al. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. Brain 136, 132–146, doi: 10.1093/brain/aws284 (2013).
Gudi, V., Gingele, S., Skripuletz, T. & Stangel, M. Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Front Cell Neurosci. 8, 73 (2014).
El-Etr, M. et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex. Glia 63, 104–117 (2015).
Faulkner, J. & Keirstead, H. S. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transplant immunology 15, 131–142 (2005).
Zhang, Y. W., Denham, J. & Thies, R. S. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem cells Dev. 15, 943–952, doi: 10.1089/scd.2006.15.943 (2006).
Piao, J. et al. Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell 16, 198–210 doi: 10.1016/j.stem.2015.01.004 (2015).
Munzel, E. A. & Williams, A. Promoting remyelination in multiple sclerosis-recent advances. Drugs 73, 2017–29, doi: 10.1007/s40265-013-0146-8 (2013).
Pluchino, S. et al. Neurosphereo- derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436, 266–271 (2005).
Webber, D. J., van Blitterswijk, M. & Chandran, S. Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia. Am J Pathol 175, 2332–2342. doi: 10.2353/ajpath.2009.090051. (2009).
Chen, L. X. et al. Neuroprotective effects of oligodendrocyte progenitor cell transplantation in premature rat brain following hypoxic-ischemic injury. PLoS One 10, e0115997, doi: 10.1371/journal.pone.0115997. eCollection 2015 (2015).
Cui, Q. L. et al. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis. Am J Pathol 183, 516–525, doi: 10.1016/j.ajpath.2013.04.016 (2013).
Franklin, R. J. M. & ffrench-Constant, C. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9, 839–855, doi: 10.1038/nrn2480 (2008).
Mason, J. L. et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am.J.Pathol. 164, 1673–1682, doi: 10.1016/S0002-9440(10)63726-1(2004).
Armastong, R. C., Le, T. Q., Flint, N. C., Vana, A. C. & Zhou, Y. X. Endogenous cell repair of chronic demyelination. J Neuropathol Exp Neurol. 65, 245–256 (2006).
Jaramillo-Merchán, J. et al. Mesenchymal stromal-cell transplants induceoligodendrocyte progenitor migration and remyelination in a chronicdemyelination model. Cell Death Dis. 4, e779, doi: 10.1038/cddis.2013.304 (2013).
Xiao, L. et al. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol. Psychiatry. 13, 697–708, doi: 10.1038/sj.mp.4002064 (2008).
Adilijiang, A. et al. The protective effects of areca catechu extract on cognition and social interaction deficits in a cuprizone-induced demyelination model. Evid Based Complement Alternat Med. 426092 (2015).
Hibbits, N., Pannu, R., John, Wu, T. & Armstrong, R. C. Cuprizone demyelination of the corpus callousm in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination. ASN Neuro. 153–164, doi: 10.1042/AN20090032 (2009).
Brunet-Gouet, E. & Decety, J. Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. Psychiatry Res 148, 75–92 (2006).
Serra-de-Oliveira, N. et al. Behavioural changes observed in demyelination model shares similarities with white matter abnormalities in humans. Behav. Brain. Res. 287, 265–275, doi: 10.1016/j.bbr.2015.03.038 (2015).
Qu, X. B., Pan, J., Zhang, C. & Huang, S. Y. Sox17 facilitates the differentiation of mouse embryonic stem cells into primitive and definitive endoderm in vitro . Dev. Growth Differ. 50, 585–593 (2008).
Akanuma, H. et al. Identification of stage-specific gene expression signatures in response to retinoic acid during the neural differentiation of mouse embryonic stem cells. Front genet. 3, 141 (2012).
Chen, Z. et al. Oligodendrocyte-spinal cord explant co-culture: an in vitro model for the study of myelination. Brain Res. 1309, 9–18. doi: 10.1016/j.brainres.2009.10.060 (2010).
Lu, J. et al. Troxerutin protects against high cholesterol-induced cognitive deficits in mice. Brain 134, 783–797, doi: 10.1093/brain/awq376 (2011).
Lu, J. et al. Troxerutin counteracts domoic acid-induced memory deficits in mice by inhibiting CCAAT/enhancer binding protein β-mediated inflammatory response and oxidative stress. J. Immunol. 7, 3466–3479, doi: 10.4049/jimmunol.1202862 (2013).
Doan, V. et al. Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss. J. Neurosci. Res. 91, 363–373 (2013).
Yao, R. Q., Zhang, L., Wang, W. & Li, L. Cornel iridoid glycoside promotes neurogenesis and angiogen-esis and improves neurological function after focal cerebral ischemia in rats. Brain Res. Bull. 79, 69–76, doi: org/10.1016/j.brainresbull.2008.12.010 (2009).
Qu, X. et al. Quercetin improves hypoxia-ischemia induced cognitive deficits via promoting remyelination in neonatal rat. Brain Res. 1553, 31–40, doi: 10.1016/j.brainres.2014.01.035 (2014).
Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N. & Franklin, R. J. Quantifying the early stages of r-emyelination following cuprizone-induced demyelination. Brain Pathol. 13, 329–339 (2003).
Hedayatpour, A. et al. Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis. Cell J. 15, 142–151 (2013).
Acknowledgements
This work was supported by grants from the National Natural Science Foundation of China (No. 81271345, 81302519), the Natural Science Foundation of Jiangsu Province (No. BK20131132, BK20130221, BK20161174), Qing Lan Project (2014 to Ruiqin Yao) and University Science Research Project of Jiangsu Province (No. 15KJB180018, 15KJB310023). We thank Sarah Toombs Smith, PhD, ELS, an Assistant Professor of Internal Medicine and Science Editor, Manager of the Manuscript Office and Fellow, Sealy Center on Aging, UTMB for reading and editing the manuscript.
Author information
Authors and Affiliations
Contributions
D.S.G. and R.Q.Y. proposed the hypothesis, designed the experiments and significantly edited the manuscript. H.B.F., L.X.C., X.B.Q. and X.X.W. performed the experiments and wrote the manuscript; C.L.R., F.X.D. and B.L.Z. analyzed the data. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Fan, HB., Chen, LX., Qu, XB. et al. Transplanted miR-219-overexpressing oligodendrocyte precursor cells promoted remyelination and improved functional recovery in a chronic demyelinated model. Sci Rep 7, 41407 (2017). https://doi.org/10.1038/srep41407
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep41407
This article is cited by
-
Paeonol Ameliorates Cuprizone-Induced Hippocampal Demyelination and Cognitive Deficits through Inhibition of Oxidative and Inflammatory Events
Journal of Molecular Neuroscience (2022)
-
A novel RIP1/RIP3 dual inhibitor promoted OPC survival and myelination in a rat neonatal white matter injury model with hOPC graft
Stem Cell Research & Therapy (2021)
-
Conditioned medium-preconditioned EPCs enhanced the ability in oligovascular repair in cerebral ischemia neonatal rats
Stem Cell Research & Therapy (2021)
-
miR-219 overexpressing oligodendrocyte progenitor cells for treating compression spinal cord injury
Metabolic Brain Disease (2021)
-
Conditional Deletion of Foxg1 Alleviates Demyelination and Facilitates Remyelination via the Wnt Signaling Pathway in Cuprizone-Induced Demyelinated Mice
Neuroscience Bulletin (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.